| NEWAMSTERDAM PHARMA |
| Niederlande |
| Gesundheit |
| NL00150012L7 / A3DUAC |
| KH6 (Frankfurt) / NAMS (NASDAQ) |
| FRA:KH6, ETR:KH6, KH6:GR, NASDAQ:NAMS |
| - |
| https://www.newamsterdamp.. |
|
NewAmsterdam Pharma Co. N.V. is a pharmaceutical c..
>Volltext.. |
| 3307.49 Mio. EUR |
| 2706.84 Mio. EUR |
| 30.04 Mio. EUR |
| -172.8 Mio. EUR |
| -188.44 Mio. EUR |
| -1.74 EUR |
| 0.23 Mio. EUR |
| 460.05 Mio. EUR |
| -123.08 Mio. EUR |
| 12.09 |
| - |
| -4974.03% |
| - |
| - |
| - |
| - |
| NEWAMSTERDAM |
| 17.12.25 |
|